BGIM
ABMD

Brandywine Global Investment Management’s Abiomed Inc ABMD Stock Holding History

Brandywine Global Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-50
Closed -$13K – 779
2020
Q2 		$13K Sell
50
-3
-6% -$602 ﹤0.01% 685
2020
Q1 		$8K Buy
+53
New +$8.8K ﹤0.01% 735

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brandywine Global Investment Management's ABMD Position: Q3 2020 in Review

Brandywine Global Investment Management sold out of Abiomed Inc (ABMD) in Q3 2020, closing a stake of 50 shares — an estimated $13K sold.

Brandywine Global Investment Management first reported a position in ABMD in Q1 2020 and held it in 2 quarters. The position peaked at $13K in Q2 2020. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2020.

  • Brandywine Global Investment Management reported no remaining Abiomed Inc position as of Q3 2020 after selling out during the quarter.
  • Brandywine Global Investment Management sold 50 Abiomed Inc shares in Q3 2020, an estimated $13K.
  • Brandywine Global Investment Management first reported a position in Abiomed Inc in Q1 2020 and held it in 2 quarters.
  • Brandywine Global Investment Management's Abiomed Inc position peaked at $13K in Q2 2020.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2020.

Based on Brandywine Global Investment Management's 13F filing for Q3 2020, filed 12 Nov 2020.